Donald P. Taylor, PhD, MBA, CLP

Current Positions 

Executive Director, Licensing 

The Ohio State University

Past Positions

Founding Executive Director


Assistant Vice Chancellor, Commercial Translation in the Health Sciences

Associate Professor, Biomedical Informatics, School of Medicine
Codirector, Center for Commercial Applications of Healthcare Data
Codirector, Clinical and Translational Science Institute, Innovation Core
Associate Director, Center for Medical Innovation
Associate Professor, Bioengineering, Swanson School of Engineering
Associate Professor, Plastic Surgery, School of Medicine
Faculty, McGowan Institute for Regenerative Medicine

Leading Commercial Translation across Pitt’s six health sciences schools to advance basic research toward market-focused solutions.

Spread the love

Education & Experience

Donald P. Taylor, PhD, MBA, CLP, is Assistant Vice Chancellor for Health Sciences Translation, Executive Director, sciVelo, Co-director, Clinical and Translational Science Institute Innovation Core, Associate Director, Center for Medical Innovation, Associate Professor of Biomedical Informatics and of Plastic Surgery, School of Medicine, and Associate Professor of Bioengineering, Swanson School of Engineering.

Dr. Taylor has more than 20 years of life sciences translational research and commercial translation experience. His current responsibilities include driving academic commercial translation across the six University of Pittsburgh Health Sciences schools (Medicine, Nursing, Pharmacy, Dental Medicine, Public Health, and Health & Rehabilitation) to accelerate commercial translation of Pitt’s discoveries and inventions, grow corporate sponsored research, secure commercial translation grants, and help train the next generation of world-class commercial translation students, staff, and faculty. Dr. Taylor’s research spans translational scientific investigations into metastatic breast cancer latency and chronic wound healing as well as new methods for health sciences commercial translation. Dr. Taylor is currently a co-investigator on two NIH-funded U01 grants including the Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center and co-investigator on an FDA-funded P50 grant to establish the Pennsylvania Pediatric Device Consortium. Prior to his academic career, Dr. Taylor served as Founder, Co-founder, Board Chairman, CEO, and Vice President across six life sciences companies – all of which have been acquired by companies including Hospira and IBM. Dr. Taylor holds a PhD in Bioengineering from the University of Pittsburgh.


PhD, Bioengineering, University of Pittsburgh, 2013
MBA, University of Pittsburgh, 2006
MS, Bioengineering, University of Pittsburgh, 2005
BS, Information Systems, Carnegie Mellon University, 1998

Research Experience

Associate Professor of Biomedical Informatics and of Plastic Surgery, School of Medicine, University of Pittsburgh, July 2016 – present

Faculty, McGowan Institute for Regenerative Medicine at UPMC, November 2014 – Present

  • Cellular, tissue, and organ engineering innovation

Postdoctoral Research, Department of Pathology, University of Pittsburgh School of Medicine, 2014

Doctoral Research, Department of Bioengineering, University of Pittsburgh, 2011-2013

Graduate Research, Department of Bioengineering, University of Pittsburgh, 2003-2005

Commercial Translation Experience

Translational Experience

Founder & Executive Director, sciVelo, July 2016 – Present

Founder & Principal Consultant at bioStratica, LLC, February 2010 – June 2016

  • Provided translational development services to universities, academic medical centers and industry that intersect biotechnology, healthcare informatics, and medicine.

Founder & Business Advisor at healthStratica, December 2014 – June 2016

  • healthStratica is a population healthcare information technology products company. healthStratica’s first product, CaringTXT, reduces binge drinking in at-risk populations and reduces alcohol-induced emergency department visits.

Adjunct Professor of Biomedical Engineering by Courtesy at Duquesne University, November 2014 – Present

Executive-in-Residence at Pittsburgh Life Sciences Greenhouse, June 2010 – June 2016

  • Biotechnology & informatics investments and executive mentorship
  • Executive Associate June 2010 – March 2012: promoted to Executive-in-Residence

Vice President, Marketing & Corporate Development at Cellumen, January 2008 – August 2010

Cell-based assays (high content) and informatics for drug discovery and toxicology

  • Cancer molecular diagnostics assays (through Cernostics spinout)
  • Senior Director of Marketing & Corporate Development Jan. 2008 – May 2009: promoted to VP
  • Acquired by Apredica in 2010

Member Board of Directors, Sculptor Developmental Technologies at St. Clair Hospital, March 2005 – April 2008

  • Wholly owned subsidiary of St. Clair Hospital
  • Healthcare information technology solutions and RFID for medication administration
  • Sculptor acquired by Hospira in 2008

Marketing Manager, Pharma/Biotech at Thermo Fisher Scientific, July 2006 – January 2008

Senior Director, Life Sciences at IBM, February 2004 – March 2006

  • Formerly Vivisimo (acquired by IBM in 2012)
  • Led sales & product development for healthcare vertical

Vice President, Business Development at SHP Data, 2001 – 2004

  • Alternate site healthcare software
  • Led sales, marketing & product management
  • Acquired by Roper Industries (NYSE: ROP) in 2014

Co-founder, President & CEO at Net Health Systems, Inc., 1993 – 2001

  • Web-based disease management HIT solutions for wound care
  • Acquired by Spectrum Equity in 2012
  • Co-founder (1993), lead developer (1993 – 1995), VP biz dev (1995 – 1998)
  • Martin, DC; Taylor, DP; Kearns, L. “An information infrastructure for long-term care,” Top Health Inf. Manage., 1997, 18(1): 10-22.

Commercialization Experience

Cell-Based Compositions, Cell-Based Bandage Devices And Systems And Methods Of Treatment Therewith, US Patent Application Filed Jan 28, 2016. US 14/772,501 (Wells, Yates, Taylor).